Partnership expansion EORTC maintains active collaborations with major partners (Medidata Solutions, CHOSA Oncology AB, Health Outcomes Observatory, Menarini) and a broad network across 50 countries, presenting ongoing opportunities to introduce complementary solutions, services, or joint research initiatives with scope for multi-year contracts.

Clinical trial scale With a large global network of 3,800 members across Europe and a portfolio spanning translational to large multi-centre phase III trials, there is significant demand for trial management, data integration, patient engagement, and TRIAL-specific technology in analytics, eConsent, and patient-reported outcomes.

Patient outcomes emphasis EORTC collaborates on standardized collection of Patient-Reported Outcomes and quality-of-life measures, signaling a strong potential for solutions in PRO data capture, analytics, dashboards, and integrating patient experience insights into trial design and reporting.

Azure and data stack The tech stack includes Azure Functions, Microsoft SQL Server, and SignalR, indicating openness to cloud-based, scalable data services, real-time collaboration, secure data pipelines, and modernization of trial data infrastructure.

Funding and scale considerations Revenue range and European-centric research focus suggest opportunities to offer cost-effective consulting, grant support services, and funded-partner solutions that align with non-profit, translational research budgets and multi-country program management.